A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

Depression impacts an estimated 18 million Americans each year, yet depression screening rarely occurs in the outpatient ...

Machine learning analysis of voice recordings shows promise for detecting depression, with over 70% accuracy, improving ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

“Major depression is one of the greatest health ... “The longer we can keep patients from having severe symptoms from reoccurring improves their overall prognosis over the course of their ...

A study appearing in The Annals of Family Medicine evaluated an AI-based machine learning biomarker tool that uses speech patterns to detect moderate to severe depression, aiming to improve access ...